Additionally, Il18−/− mice with dyslipidemia, NAFLD, and NASH showed inhibition of the Wnt signaling pathway, reduced expression of cyclin D1 (Ccnd1), and disturbances in the circadian rhythm [8]. This evidence concerns the gene IL18 and metabolic dysfunction-associated steatotic liver disease.